Top news stories from AMA Morning Rounds®: Week of June 26, 2023
In the news: Eli Lilly’s experimental weight loss drug, updated physical activity guidelines for older adults, fentanyl laced with xylazine and more.
Younger and sicker: Trends presage “tsunami” of heart problems
Data on 13,000 young adults shows rising prevalence of cardiovascular risk factors. Learn why it amounts to a “smoldering public health crisis.”
COVID-19 tied to higher diabetes risk—but vaccination helps
SARS-CoV-2 infection is linked to diabetes risk. Find out how much COVID-19 vaccination lowers the risk.
Top news stories from AMA Morning Rounds®: Week of Feb. 13, 2023
In the news: children missing out on vital nutrition, early indicators of CVD and cognitive ability, COVID-19’s link to diabetes, FDA drug approvals and more.
Prediabetes is rising in kids, but hold off on screening—for now
Prediabetes has more than doubled in U.S. kids in recent years, but a study found insufficient evidence to support screening asymptomatic children.
Top news stories from AMA Morning Rounds®: Week of Oct. 17, 2022
In the news: ACIP recommends COVID-19 shots for 2023 vaccination schedules, insulin rationing in U.S., earliest warning signs of dementia and more.
Top news stories from AMA Morning Rounds®: Week of May 30, 2022
In the news: Melatonin poisoning in kids, PBM price gouging on generics, links between T2D and brain aging, daily e-cigarette use in youth and more.
Time to step up screening for prediabetes and type 2 diabetes
As knowledge grows about the link between type 2 diabetes and COVID-19, so does the need to help patients prevent this devastating chronic condition.